P
Pinakel
Trademark Analytics
Search/Trademark

QUOMELVA

Cancelled
US US · App #87061737 · Reg #5230955
Owned by
Glaxo Group Limited
Application date
2016-06-06
Registration date
2017-06-27
Published date
—
First use date
—
Renewal date
—
Expiry date
—
Kind of mark
Trademark
Mark feature
Word

NICE Classes

5Pharmaceuticals

Domestic Classes

Jurisdiction-specific classifications outside WIPO 1-45 (e.g. US old classes).

006018044046051052

Current owners

Applicants

  • Glaxo Group Limited

Previous owners

  • Glaxo Group Limited
  • Glaxo Group Limited

Correspondence

  • [Christopher M. Hanes] GSK

Activity Summary

Oppositions
0
P 0 · D 0
Assignments
0
Security: 0
Renewals
0
Prosecution events
25

Prosecution History

25 events
DateEvent
2024-01-12CANCELLED SEC. 8 (6-YR)
2022-11-08TEAS CHANGE OF CORRESPONDENCE RECEIVED
2022-11-08ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2022-11-08TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2022-06-27COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2019-12-05ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2019-12-05TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2017-06-27REGISTERED-PRINCIPAL REGISTER
2017-04-11OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-04-11PUBLISHED FOR OPPOSITION
2017-03-22NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-03-09ELECTRONIC RECORD REVIEW COMPLETE
2017-03-03ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
2017-02-23APPROVED FOR PUB - PRINCIPAL REGISTER
2017-02-22TEAS/EMAIL CORRESPONDENCE ENTERED
2017-02-21CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-02-21TEAS RESPONSE TO OFFICE ACTION RECEIVED
2017-02-14ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2017-02-14TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2016-08-21NOTIFICATION OF NON-FINAL ACTION E-MAILED
2016-08-21NON-FINAL ACTION E-MAILED
2016-08-21NON-FINAL ACTION WRITTEN
2016-08-17ASSIGNED TO EXAMINER
2016-06-13NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
2016-06-09NEW APPLICATION ENTERED